Literature DB >> 2801333

Pharmacologic modulation of D-49 phospholipase A2-induced paw edema in the mouse.

W Calhoun1, J Yu, A Sung, T T Chau, L A Marshall, B M Weichman, R P Carlson.   

Abstract

Paw edema was produced in CD-1 mice by the injection of 0.3 micrograms of snake venom PLA2 (A.p. piscivorus D-49) into the hind paw. Edema peaked at 10 min, remained elevated until 60 min, and then declined slowly. The PLA2 inhibitors, luffariellolide and aristolochic acid, reduced the edema but only when coinjected with the PLA2. The histamine/serotonin antagonists were the most effective drug class against PLA2-induced paw edema. The PAF antagonists, CV-6202 (iv) and kadsurenone (coinjected) reduced the PLA2-induced edema, whereas high doses of the corticosteroids, dexamethasone and hydrocortisone, were also effective. NSAIDs only partially inhibited the paw edema. The LO/CO inhibitors yielded varying activities, with only BW755C and NDGA inhibiting the edema. These results suggest that PLA2 induces paw edema in the mouse via the action of several classes of inflammatory mediators.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2801333     DOI: 10.1007/bf01972839

Source DB:  PubMed          Journal:  Agents Actions        ISSN: 0065-4299


  6 in total

1.  Lipoxygenase products modulate histamine release in human basophils.

Authors:  S P Peters; M I Siegel; A Kagey-Sobotka; L M Lichtenstein
Journal:  Nature       Date:  1981-07-30       Impact factor: 49.962

2.  Possible role of phospholipase A2 in triggering histamine secretion from human basophils in vitro.

Authors:  G Marone; A Kagey-Sobotka; L M Lichtenstein
Journal:  Clin Immunol Immunopathol       Date:  1981-08

Review 3.  A role for PAF-acether (platelet-activating factor) in platelet-dependent vascular diseases?

Authors:  J Benveniste; M Chignard
Journal:  Circulation       Date:  1985-10       Impact factor: 29.690

4.  Interaction of aristolochic acid with Vipera russelli phospholipase A2: its effect on enzymatic and pathological activities.

Authors:  B S Vishwanath; T V Gowda
Journal:  Toxicon       Date:  1987       Impact factor: 3.033

5.  Edema-inducing activity of phospholipase A2 purified from human synovial fluid and inhibition by aristolochic acid.

Authors:  B S Vishwanath; A A Fawzy; R C Franson
Journal:  Inflammation       Date:  1988-12       Impact factor: 4.092

6.  Characterization of extracellular phospholipase A2 in rheumatoid synovial fluid.

Authors:  P Vadas; E Stefanski; W Pruzanski
Journal:  Life Sci       Date:  1985-02-11       Impact factor: 5.037

  6 in total
  5 in total

1.  Anti-inflammatory effect of Acacia visco extracts in animal models.

Authors:  Ana María Pedernera; Teresita Guardia; Carola Elisa Guardia Calderón; Alejandra Ester Rotelli; Nadir Ernesto de la Rocha; José Roberto Saad; María Alejandra Lopez Verrilli; Susana Garcia Aseff; Lilian Eugenia Pelzer
Journal:  Inflammopharmacology       Date:  2010-01-20       Impact factor: 4.473

2.  Pharmacological study of edema and myonecrosis in mice induced by venom of the bushmaster snake (Lachesis muta muta) and its basic Asp49 phospholipase A(2) (LmTX-I).

Authors:  Daniela C S Damico; Maria Alice da Cruz Höfling; Mariana Cintra; Marta B Leonardo; Andrana K Calgarotto; Saulo L da Silva; Sérgio Marangoni
Journal:  Protein J       Date:  2008-09       Impact factor: 2.371

3.  Selective inhibition of group II phospholipase A2 by quercetin.

Authors:  M Lindahl; C Tagesson
Journal:  Inflammation       Date:  1993-10       Impact factor: 4.092

4.  Comparison of antiinflammatory and antiallergic drugs in the melittin- and D49 PLA2-induced mouse paw edema models.

Authors:  D A Hartman; L A Tomchek; J R Lugay; A C Lewin; T T Chau; R P Carlson
Journal:  Agents Actions       Date:  1991-09

5.  Pharmaco-modulations of induced edema and vascular permeability changes by Vipera lebetina venom: inflammatory mechanisms.

Authors:  Fatima Sebia-Amrane; Fatima Laraba-Djebari
Journal:  Inflammation       Date:  2013-04       Impact factor: 4.092

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.